Abstract:Objective: The objective of this study was to compare the outcomes of pharmacomechanical thrombolysis and thrombectomy (PCDT) plus catheter-directed thrombolysis (CDT) vs CDT alone for the treatment of acute iliofemoral deep vein thrombosis (DVT) and summarize the clinical experience, safety outcomes, and short- and long-term efficacy.Methods: We performed a 4-year retrospective, case-control study. A total of 95 consecutive patients with acute symptomatic iliofemoral deep vein thrombosis (DVT) with a symptom duration of <= 7 days involving the iliac and/or common femoral veins underwent endovascular interventions. The patients were divided into two groups according to their clinical indications: PCDT plus CDT vs CDT alone. Statistical analyses were used to compare the clinical characteristics and outcomes between the two groups. Additionally, the patients were followed up for 3 to 36 months after treatment, and the proportions of post-thrombotic syndrome (PTS) and moderate to severe PTS were analyzed using the Kaplan-Meier survival method.Results: A total of 95 consecutive patients were analyzed in this retrospective study, of whom, 51 underwent CDT alone and 44 underwent PCDT plus CDT. Between the two groups, in terms of immediate-term efficacy and safety, significant differences were found in the catheter retention time (60.64 +/- 12.04 hours vs 19.42 +/- 4.04 hours; P < .001), dosages of urokinase required (5.82 +/- 0.81 million units vs 1.80 +/- 0.64 million units; P < .001), the detumescence rate at 24 hours postoperatively (48.46% +/- 8.62% vs 76.79% +/- 7.98%; P = .026), the descent velocity of D-dimer per day (2266.28 +/- 1358.26 mu g/L/D vs 3842.34 +/- 2048.02 mu g/L/D; P = .018), total hospitalization stay (6.2 +/- 1.40 days vs 3.8 +/- 0.70 days; P = .024), number of postoperative angiograms (2.4 +/- 0.80 vs 1.2 +/- 0.30; P = .042), and grade III venous patency (>95% lysis: 54.5% vs 68.6%; P = .047). Furthermore, during the follow-up period, significant differences were found in the incidence of PTS (Villalta scale >= 5 or a venous ulcer: 47.0% vs 27.7%; P = .037), and the incidence proportion of moderate to severe PTS at 12 months (15.7% vs 4.5%; P = .024) and 24 months (35.3% vs 11.4%; P = .016).Conclusions: Compared with CDT alone, in the iliofemoral DVT subgroup with a symptom duration of <= 7 days, PCDT plus CDT could significantly relieve early leg symptoms, shorten the hospitalization stay, reduce bleeding complications, promote long-term venous patency, and decrease the occurrence of PTS and the incidence proportion of moderate to severe PTS. Thus, the short- and long-term outcomes both support the superiority of PCDT plus CDT vs CDT in this subgroup.

Comparison of catheter-directed thrombolytic therapy of alteplase and urokinase for the treatment of acute iliofemoral venous thrombosis

Comparative Outcomes of Catheter-Directed Thrombolysis versus AngioJet Pharmaco-mechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis

Catheter-directed Thrombolysis Compared with Anticoagulation Treatment for Acute Deep Venous Thrombosis-Short and Mid-Term Result

Comparative Outcomes of Catheter-Directed Thrombolysis Versus AngioJet Pharmacomechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis.

A clinical study of high-dose urokinase for the treatment of the patients with hypertension induced ventricular hemorrhage

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction

Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity

Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis

Ultrasound-guided versus non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis

Early Tirofiban Administration for Patients with Acute Ischemic Stroke Treated with Intravenous Thrombolysis or Bridging Therapy: Systematic Review and Meta-Analysis

Analysis of the efficacy of angiojet percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in the treatment of subacute iliofemoral deep venous thrombosis in elderly patients

Rapid pumping of urokinase in the catheter-directed thrombolysis for the management of acute deep vein thrombosis

Application evaluation of different approaches for catheter-directed thrombolysis in acute lower-extremity deep venous thrombosis

Effectiveness and safety of catheter-directed thrombolysis in conjunction with percutaneous mechanical thrombectomy for acute iliofemoral deep vein thrombosis: A meta-analysis

Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction.

Intervention Combined Surgery for the Treatment of Acute Iliofemoral Vein Thrombosis

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

The role of D-dimer and fibrinogen testing in catheter-directed thrombolysis with urokinase for deep venous thrombosis

Outcome Comparisons of Anticoagulation, Systematic Thrombolysis and Catheter-Directed Thrombolysis in the Treatment of Lower Extremity Acute Deep Venous Thrombosis

Comparison of Emergency Percutaneous Coronary Intervention and Intravenous Thrombolysis with Urokinase Combined with Emergency Percutaneous Coronary Intervention for Acute Myocardial Infarction

A new method of monitoring catheter-directed thrombolysis for deep venous thrombosis—application of D-dimer and fibrinogen testing